|Ms. ValÃ©rie Lorentz-Poinsot||GM & Exec. Director||841.1k||N/A||1969|
|Mr. Jean-Christophe Bayssat||Deputy GM, Chief Pharmacist & Director of Pharmaceutical Devel.||1.18M||N/A||1963|
|Eric Lambert||Admin. & Financial Director||N/A||N/A||N/A|
|David Soussan||Group Marketing Director||N/A||N/A||N/A|
|Patrice Varraut||Sales Director||N/A||N/A||N/A|
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines; and proprietary, branded homeopathic medicines. Its branded homeopathic medicines include Oscillococcinum to treat flu like symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; and SÃ©datif PC to treat anxiety and emotional, and minor sleep disorders. The company's branded homeopathic medicines also comprise Coryzalia for the treatment of cold symptoms and rhinitis; HomÃ©optic to treat ocular discomfort and irritation due to various causes for adults and children; and HomÃ©ovox for vocal disorders. It offers its products through distribution centers, pharmacy chains, wholesalers, supermarkets, drugstores, and health food stores. Boiron SA was founded in 1932 and is headquartered in Messimy, France.
Boiron SA’s ISS governance QualityScore as of 8 December 2019 is 9. The pillar scores are Audit: 5; Board: 9; Shareholder rights: 7; Compensation: 9.